Literature DB >> 24698848

Metal-dependent amyloid β-degrading catalytic antibody construct.

Yasuhiro Nishiyama1, Hiroaki Taguchi1, Mariko Hara1, Stephanie A Planque1, Yukie Mitsuda1, Sudhir Paul2.   

Abstract

Catalytic antibodies (catabodies) that degrade target antigens rapidly are rare. We describe the metal-dependence of catabody construct 2E6, an engineered heterodimer of immunoglobulin light chain variable domains that hydrolyzes amyloid β peptides (Aβ) specifically. In addition to the electrophilic phosphonate inhibitor of serine proteases, the metal chelators ethylenediaminetetraacetic acid (EDTA) and 1,10-phenanthroline completely inhibited the hydrolysis of Aβ by catabody 2E6. Formation of catabody-electrophilic phosphonate inhibitor adducts was unaffected by EDTA, suggesting that the metal exerts a favorable effect on a catalytic step after the initial catabody nucleophilic attack on Aβ. The EDTA inactivated catabody failed to disaggregate fibrillar Aβ, indicating the functional importance of the Aβ hydrolytic activity. Treating the EDTA-inactivated catabody with Zn(2+) or Co(2+) restored the Aβ hydrolytic activity, and Zn(2+)-induced catabody conformational transitions were evident by fluorescence emission spectroscopy. The studies reveal the absolute catabody dependence on a metal cofactor.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Amyloid β clearance; Catalytic antibody light chain; Metal activation

Mesh:

Substances:

Year:  2014        PMID: 24698848      PMCID: PMC4512298          DOI: 10.1016/j.jbiotec.2014.03.026

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  46 in total

1.  Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates.

Authors:  Evette S Radisky; Justin M Lee; Chia-Jung Karen Lu; Daniel E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Removal and replacement of metal ions in metallopeptidases.

Authors:  D S Auld
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 3.  Superantibody activities: new players in innate and adaptive immune responses.

Authors:  H Kohler; S Paul
Journal:  Immunol Today       Date:  1998-05

4.  Kinetic analysis of the activation-and-inhibition dual effects of cobalt ion on thermolysin activity.

Authors:  Yasuhiko Hashida; Kuniyo Inouye
Journal:  J Biochem       Date:  2007-04-03       Impact factor: 3.387

Review 5.  Involvement of neutral endopeptidase in neoplastic progression.

Authors:  Makoto Sumitomo; Ruoqian Shen; David M Nanus
Journal:  Biochim Biophys Acta       Date:  2004-11-17

6.  Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.

Authors:  Paul A Ramsland; Simon S Terzyan; Gwendolyn Cloud; Christina R Bourne; William Farrugia; Gordon Tribbick; H Mario Geysen; Carolyn R Moomaw; Clive A Slaughter; Allen B Edmundson
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

7.  Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis.

Authors:  Dar'ya I Polosukhina; Tat'yana G Kanyshkova; Boris M Doronin; Olga B Tyshkevich; Valentina N Buneva; Alexey N Boiko; Evgenii I Gusev; Georgy A Nevinsky; Olga O Favorova
Journal:  Immunol Lett       Date:  2005-11-15       Impact factor: 3.685

8.  Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity.

Authors:  Yasuhiro Nishiyama; Yukie Mitsuda; Hiroaki Taguchi; Stephanie Planque; Mariko Hara; Sangeeta Karle; Carl V Hanson; Taizo Uda; Sudhir Paul
Journal:  J Mol Recognit       Date:  2005 Jul-Aug       Impact factor: 2.137

Review 9.  Insulin degradation: progress and potential.

Authors:  W C Duckworth; R G Bennett; F G Hamel
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

10.  Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.

Authors:  M M Bernardo; D E Day; H R Halvorson; S T Olson; J D Shore
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  7 in total

Review 1.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  Specific amyloid β clearance by a catalytic antibody construct.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Sari Sonoda; Yan Lin; Hiroaki Taguchi; Mariko Hara; Steven Kolodziej; Yukie Mitsuda; Veronica Gonzalez; Hameetha B R Sait; Ken-ichiro Fukuchi; Richard J Massey; Robert P Friedland; Brian O'Nuallain; Einar M Sigurdsson; Sudhir Paul
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 3.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

4.  Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer's disease.

Authors:  Thanchanok Puksasook; Shinya Kimura; Sarin Tadtong; Jutamas Jiaranaikulwanitch; Jaturong Pratuangdejkul; Worawan Kitphati; Khanit Suwanborirux; Naoki Saito; Veena Nukoolkarn
Journal:  J Nat Med       Date:  2017-06-09       Impact factor: 2.343

Review 5.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 6.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

7.  Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.

Authors:  Éva Bartus; Gábor Olajos; Ildikó Schuster; Zsolt Bozsó; Mária A Deli; Szilvia Veszelka; Fruzsina R Walter; Zsolt Datki; Zsolt Szakonyi; Tamás A Martinek; Livia Fülöp
Journal:  Molecules       Date:  2018-10-02       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.